ʻO ka hōʻemi ʻana i nā lāʻau lapaʻau i hoʻokaʻina ʻia i ʻike ʻia me nā statins ʻaʻole hiki ke pale aku i ka maʻi cardiovascular wale nō, akā e hoʻonui pū i nā manawa kūpono o ka hoʻomohala ʻana i ke ʻano type 2 - ʻo ia nā hopena o kahi aʻo hou.
ʻO nā manaʻo mua
"Ua hōʻike mākou i kahi pūʻulu o ka poʻe i hiki i ke koʻikoʻi no ka hoʻomohala ʻana i ke ʻano maʻi type 2. E like me kā mākou mau ikepili, hoʻonui ʻia nā statins i ka manawa e loaʻa ai ka maʻi diabetes i ka 30%," wahi a Kauka Jill Crandall, ka luna noiʻi, ka luna lapaʻau a me ka luna hoʻomalu o ka keʻena hoʻokolohua lapaʻau no ka maʻi maʻi ma ʻO Albert Einstein College of Medicine, New York.
Akā, hoʻohui ʻo ia, ʻaʻole kēia ke manaʻo e hōʻole ʻoe e lawe i statins. "ʻO nā pōmaikaʻi o kēia mau lāʻau lapaʻau e pili ana i ka pale ʻana i nā maʻi cardiovascular nui loa a no laila ke hōʻike maoli nei i ko mākou noi ʻana ʻaʻole e pau ka lawe ʻana iā lākou, akā, ʻo ka poʻe e lawe iā lākou, e hoʻāʻo pinepine ʻia no ka maʻi maʻi. "
ʻO kekahi hāleʻa maʻi maʻi maʻamau, ʻo Dr. Daniel Donovan, ke kauka lāʻau lapaʻau a me ke poʻo o ka Center Research Clinical ma ke Aikan School of Medicine ma ka Mount Sinai Institute of Diabetes, Obesity a me Metabolism ma New York, i ʻae me kēia noi.
"Pono mākou e kuhikuhi i nā statins me nā kolamu" kino "kiʻekiʻe. ʻO kā lākou hoʻohana e hōʻemi i ka hiki ke hoʻomohokū ʻia i ka maʻi cardiovascular e ka 40%, a hiki i ka maʻi maʻi maʻi hiki ke hele pū me lākou," wahi a Kauka Donovan.
Nā hōʻike kikoʻī
ʻO ka loiloi hou kahi hōʻike noiʻina o ka ʻike mai kahi hoʻokolohua e hoʻomau mau nei aia ma kahi o 3200 mau maʻi maʻi maʻi ma kahi o 27 mau kikowaena maʻi US e komo nei.
ʻO ke kumu o ka hoʻokolohua ʻo ia e pale i ka hoʻomohala ʻana o ke ʻano maʻi diabetes type 2 i ka poʻe me kahi predisposition o kēia maʻi. ʻO nā mea a pau o ka hui e kōkua i ke kau a keu paha. Loaʻa nā hōʻailona āpau o ka metabolism kīnā koko, akā ʻaʻole i hōʻike ʻia ke nānā aku nei me ka maʻi Diabetes 2.
Ua kono ʻia lākou e komo i kahi papahana o 10 mau makahiki kahi e ana ai i nā pae kōʻai koko i ʻelua mau makahiki i kēlā me kēia makahiki a nānā i kā lākou statin intake. I ka hoʻomakaʻana o ka papahana, e pili ana i ka 4 pakeneka o nā mea komo i lawe i nā statins, e kokoke kokoke ana i kona hoʻokau ʻia ma kahi o 30%.
Ua nānā aku nō hoʻi nā kānaka loea nānā i ka hana a me ka pale ʻana i ka insulin, wahi a Kauka Crandall. ʻO ka insulin he hormone ia e kōkua ai i ke kino e hoʻokaʻawale i ke kō mai ka meaʻai i nā mea ʻala me nā wahie.
No kēlā mau mea lawe i nā statins, ua emi nā hana o ka insulin. A me kahi wā o ka emi ʻana o kona kō i ke koko, e hoʻonui ana ka ʻike o ke kō. Eia naʻe, ʻaʻole i hōʻike ʻia ka hopena o nā statins i ka pale ʻana i ka insulin.
Kauike o na kauka
Ua hōʻoia ʻo Kauka Donovan he mea nui loa ka ʻike i loaʻa. "ʻAʻole wau e manaʻo e pono ʻoe e hāʻawi i nā statins. He mea nui paha ia e ʻae mua ka maʻi o ka puʻuwai, a no laila e pono ke hoʻāʻo e hōʻemi i nā pilikia e noho nei," wahi āna.
"ʻOiai ʻaʻole lākou i komo i ka hoʻopaʻa ʻana, ʻo ka poʻe me ka maʻi o ka maʻi maʻi maʻi type 2 e pono e kiaʻi hou i ka nui o ke kōpaʻa koko inā makemake lākou i statins," wahi a Kauka Crandall. "He liʻiliʻi nā data i kēia wā, akā aia kekahi mau manawa i hala ke piʻi ʻana o ke kō me nā statins."
Hoike pū ke kauka ʻo ka poʻe i kū i ka hopena ʻole o ka hoʻomohala ʻana i ka maʻi diabetes ʻaʻole hiki ke hoʻopilikia i nā statins. ʻO kēia mau mea pilikia keu aku ka mea nui o ka momona, ke kiʻekiʻe kiʻekiʻe, ke koko kiʻekiʻe, a me nā hihia o ka maʻi diabetes i ka ʻohana. ʻO ka mea pōʻino, ua ʻōlelo ke kauka, he nui ka poʻe ma hope o ka 50 e hoʻomohala ai i ka prediabetes, a lākou e ʻike ʻole ai, a pono nā hopena o ka noiʻi.
